Arkolith/Insider Trading/CLDX/Form 4

Pepin Ronald

SR. VP & CBOCelldex Therapeutics, Inc. (CLDX) · full profile →Form 4 · filed Dec 17, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2025Option exercise(M)8K$9.02$75K9K
Dec 15, 2025Option exercise(M)11K$2.78$31K20K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2025Option exercise(M)8K—$05K
Dec 15, 2025Option exercise(M)11K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214504-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML